Enzymatic amplification of exogenous and endogenous retroviral sequences from DNA of patients with tropical spastic paraparesis.
about
Novel human endogenous sequences related to human immunodeficiency virus type 1.Tropical spastic paraparesis and human T-cell lymphotropic virus type 1.Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.Mouse model for the equilibration interaction between the host immune system and human T-cell leukemia virus type 1 gene expressionDetection of HTLV-I proviral sequences in CD30-positive large cell cutaneous T-cell lymphomas.Transactivation of the human T-cell lymphotropic virus type 1 Tax1-responsive 21-base-pair repeats requires Holo-TFIID and TFIIATranscription of the human T-cell lymphotropic virus type I promoter by an alpha-amanitin-resistant polymerase.Isolation of a human T-lymphotropic virus type I strain from Australian aboriginals.Transcriptional activation of the human T-lymphotropic virus type I long terminal repeat by functional interaction of Tax1 and Ets1.Transdominant human T-cell lymphotropic virus type I TAX1 mutant that fails to localize to the nucleus.In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologiesSequence-specific interaction of the Ets1 protein with the long terminal repeat of the human T-lymphotropic virus type I.Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates.Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax.Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response.
P2860
Q31121071-C2C3D507-AB6F-4C11-8BE8-7637D78EF732Q33588602-55376519-E664-46E2-AD05-A1A64E0C9975Q33676408-ABB84353-4F42-460B-B9E6-527EF17ACF7DQ34332433-44584771-BBA0-4729-8D25-5D204FFF6FF6Q35812183-1843465C-4DF2-40C0-8158-E87AE212BDBEQ35845222-B1E1E00D-0F83-4B98-B33C-5D4C7BE77D36Q36635734-5A878B68-179C-491F-8116-69DB25F1F361Q36641284-0B2E62F1-C807-488F-90F7-E709BF034B8BQ36655224-68BB5662-59FA-4841-BB44-CF0CDCFE9B1BQ36689080-000D71BE-4F54-4CD0-8FAD-0E7831771E49Q36701505-50345289-26D5-4566-9CF2-69644EA9ABCFQ36798336-0FE4174C-54D8-4136-9D74-080A005F9AA1Q36802420-7247F8E9-4EB5-46B0-A80B-22531D29CBECQ39869820-21AAECFB-F3DB-4C9B-8BFC-6632C9AB5472Q39875392-05DFE9AF-EE13-4425-B085-13325AEF55DE
P2860
Enzymatic amplification of exogenous and endogenous retroviral sequences from DNA of patients with tropical spastic paraparesis.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Enzymatic amplification of exo ...... tropical spastic paraparesis.
@ast
Enzymatic amplification of exo ...... tropical spastic paraparesis.
@en
type
label
Enzymatic amplification of exo ...... tropical spastic paraparesis.
@ast
Enzymatic amplification of exo ...... tropical spastic paraparesis.
@en
prefLabel
Enzymatic amplification of exo ...... tropical spastic paraparesis.
@ast
Enzymatic amplification of exo ...... tropical spastic paraparesis.
@en
P2093
P2860
P1433
P1476
Enzymatic amplification of exo ...... h tropical spastic paraparesis
@en
P2093
J K Cruickshank
R E Phillips
P2860
P304
P356
10.1002/J.1460-2075.1988.TB03314.X
P407
P577
1988-12-01T00:00:00Z